Torrent Pharma Inc, a wholly owned subsidiary of India-based Torrent Pharmaceuticals Limited, announced on Thursday that it has commenced shipping the generic version of Xeris's Keveyis (dichlorphenamide), 50mg tablets in the United States.
This follows final approval from the US Food and Drug Administration (FDA) for it its Abbreviated New Drug Application. Torrent is distributing the product through specialty pharmacies beginning this month.
Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis and related variants, a rare condition that causes sudden episodes that affect the muscles, resulting in extreme muscle weakness or temporary paralysis – most often the inability to move the muscles of the arms and legs.
Upsher-Smith launches Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%/0.5%
Torrent Pharma starts shipping generic Keveyis (dichlorphenamide), 50mg tablets in US
Upsher-Smith Laboratories introduces Fluphenazine Hydrochloride Tablets
American Regent launches sulphite-free Epinephrine Injection
Teva and Natco Launch Additional Strengths for the Generic Version of Revlimid in the US
Accord Healthcare adds Teriflunomide to oral medications range